HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 51 filers reported holding HARPOON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $46,000 | -38.7% | 9,287 | -6.6% | 0.00% | – |
| Q4 2021 | $75,000 | -7.4% | 9,940 | -2.9% | 0.00% | – |
| Q3 2021 | $81,000 | -44.1% | 10,238 | -2.3% | 0.00% | – |
| Q2 2021 | $145,000 | -12.1% | 10,481 | +32.7% | 0.00% | -100.0% |
| Q1 2021 | $165,000 | +58.7% | 7,896 | +26.5% | 0.00% | – |
| Q4 2020 | $104,000 | -2.8% | 6,241 | -1.3% | 0.00% | -100.0% |
| Q3 2020 | $107,000 | 0.0% | 6,323 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $107,000 | +114.0% | 6,467 | +49.0% | 0.00% | – |
| Q1 2020 | $50,000 | -26.5% | 4,341 | -5.5% | 0.00% | – |
| Q4 2019 | $68,000 | +7.9% | 4,593 | +0.3% | 0.00% | – |
| Q3 2019 | $63,000 | +28.6% | 4,580 | +21.5% | 0.00% | – |
| Q2 2019 | $49,000 | +226.7% | 3,771 | +130.5% | 0.00% | – |
| Q1 2019 | $15,000 | – | 1,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $58,818,000 | 23.77% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $37,978,000 | 10.18% |
| EcoR1 Capital, LLC | 1,348,423 | $17,529,000 | 1.77% |
| SPHERA FUNDS MANAGEMENT LTD. | 374,031 | $4,862,000 | 0.66% |
| Orbimed Advisors | 2,446,409 | $31,803,000 | 0.49% |
| Cormorant Asset Management, LP | 649,994 | $8,450,000 | 0.48% |
| Fosun International Ltd | 323,400 | $4,205,000 | 0.28% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 285,000 | $3,705,000 | 0.13% |
| Baker Brothers Advisors | 214,285 | $2,786,000 | 0.02% |
| NEW YORK STATE COMMON RETIREMENT FUND | 500 | $7,000 | 0.00% |